NEW YORK--(BUSINESS WIRE)--Emotional Intelligence Ventures (Ei.Ventures or Ei), Inc, the leader in all-natural psychedelic medicine development, today announced that it has been qualified by the Securities and Exchange Commission (SEC) to list a $50 million exempt public stock offering using the Regulation A+ Tier 2 framework. This is only the second public stock offering in the psychedelic medicine space in the U.S. and the first for a company developing products only from all-natural botanical material. A Regulation A+ offering allows for retail investors to invest in pre-public and private companies. The net proceeds of the offering will be used to accelerate the development and distribution of Ei’s medicinal and functional mushroom product lines.
Ei.Ventures is launching this offering as the public needs real access to novel therapies that can reverse, heal, and treat chronic mental health disorders. Ei is the only company poised to bring botanical psychedelic therapies, functional plant medicines, and integrative technology to the market in an acceptable time frame of under 2 years. Due to Covid, lockdowns, and the economic impact of the pandemic, the state of Americans’ mental health has declined significantly over the past year. Ei.Ventures’ solutions need to come to the market as soon as possible and Ei wants to give the retail-investing public a chance to participate in the upside potential of this exciting new field of healthcare.
“While we have raised money with our friends & family and private placement raises, we are so committed to the unaccredited investor, that we’ve engaged with the SEC for a Reg A+,” said David Nikzad, founder and CEO of Ei.Ventures. “As I’ve been fortunate to invest early in numerous companies like Airbnb, Betterment, and Vidyard, and three equity crowdfunding platforms (WeFunder, RealCrowd, Republic), I’m really passionate about democratizing investment opportunities so any investor can reap the rewards, and take all of the risks of early investment in game-changing companies.”
“We believe that this offering may be the first time an all-natural psychedelic medicine project received approval to access the public U.S. markets and we are excited to continue to pursue our capital markets pathway in the U.S. and Canada,” Nikzad continued. “This can potentially set a precedent for others in the industry.”
About Ei.Ventures
Empowering mental wellness through psychoactive compounds and technology, Ei.Ventures’ has the largest psychedelic compound library in the world. Our mission is to provide real access to these sacred medicines and compounds to the billion people world-wide suffering from persistent mental health disorders.
Connect with Ei.Ventures: Website | LinkedIn | Twitter
Legend: AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AT: https://www.sec.gov/Archives/edgar/data/1823182/000110465921038430/a20-30556_1partiiandiii.htm YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.
Forward Looking Statements: Certain information set forth in this presentation, together with any supplements and any other information that may be furnished to prospective investors by the Company in connection therewith, contains “forward-looking statements” and “forward-looking information” within the meaning of applicable United States securities legislation (referred to herein as forward-looking statements). Except for statements of historical fact, certain information contained herein constitutes forward-looking statements which include but are not limited to statements related to activities, events or developments that Ei.Ventures expects or anticipates will or may occur in the future, statements related to the Company’s business strategy objectives and goals, and management’s assessment of future plans and operations which are based on current internal expectations, estimates, projections, assumptions and beliefs, which may prove to be incorrect. Forward-looking statements can often be identified by the use of words such as “may”, “will”, “could”, “would”, “anticipate”, ‘believe”, expect”, “intend”, “potential”, “estimate”, “budget”, “scheduled”, “plans”, “planned”, “forecasts”, “goals” and similar expressions or the negatives thereof. Forward-looking statements are neither historical facts nor assurances of future performance. Forward-looking statements are based on a number of factors and assumptions made by management and considered reasonable at the time such information is provided, and forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements.
